Audrius V Plioplys is a Chicago, Illinois based neurologist who is specialized in Child Neurology. His current practice location is 8844 S Pleasant Ave, Chicago. Patients can reach him at 708-445-5060 or can fax him at 773-445-0123. Audrius V Plioplys is MD in Child Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1386639342. Audrius V Plioplys specializes in neurology with special skills in diagnosis and treatment of neurologic disorders of the neonatal period, infancy, early childhood, and adolescence.
Complete Profile:
Audrius V Plioplys speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Audrius V Plioplys
Specialization:
Child Neurology
Gender:
Male
Credentials:
MD
Practice Address:
8844 S Pleasant Ave, Chicago, Illinois, 60620-5441
Phone:
708-445-5060
Fax:
773-445-0123
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1386639342
NPI Enumeration Date:
15 Sep, 2005
NPI Last Update On:
11 Mar, 2008
Other Medical Identifiers:
Other legacy medical identifiers associated with Audrius V Plioplys such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
2232936
Other
Illinois
BCBS PROVIDER ID
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Audrius V Plioplys 777 Oakmont Ln, Suite 1600 Westmont, Illinois
Zip:
60559-5511
Phone Number:
630-789-2550
Patients can reach Audrius V Plioplys at 8844 S Pleasant Ave, Chicago, Illinois or can call to book an appointment on 708-445-5060.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.